Login / Signup

Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study.

Maryanne Y SourialAnirudh GoneJaime UribarriVesh SrivatanaShuchita SharmaDaniil ShimonovMichael ChangWenzhu MowreyRochelle DalsanKaltrina SedaliuSwati JainMichael J RossNina CaplinWei Chennull null
Published in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2022)
The use of PD for the treatment of AKI was not associated with worse clinical outcomes when compared to extracorporeal dialysis during the height of the COVID-19 pandemic in New York City. Given the inherent selection biases and residual confounding in our observational study, research with a larger cohort of patients in a more controlled setting is needed to confirm our findings.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • acute kidney injury
  • peritoneal dialysis
  • newly diagnosed
  • prognostic factors
  • skeletal muscle
  • adipose tissue
  • replacement therapy
  • patient reported